Stay up to date on COVID-19. Learn more
Everything You Need to Know About Clinical Trials in One Place
May 21, 2026
May 20 is ClinicalInvolving direct observation of a patient. Trials Day, a…
5 Tips to Boost Your Myeloma Canada Ride Fundraising
May 21, 2026
Fundraising doesn’t have to feel overwhelming. Whether you’re a first-time rider or a seasoned cyclist, these…
New Faces, Fresh Ideas: Welcoming Our Newest Board Members and Staff
May 21, 2026
Myeloma Canada is growing, and we couldn’t be more excited about the people joining…
The Continuous Work of Advocacy
May 20, 2026
From the day Myeloma Canada was founded in 2005, our co-founder Aldo Del…
Announcing the 2026 Marion State Memorial Nursing Award Recipient: Nina Mason
May 8, 2026
Myeloma Canada is proud to announce Nina Mason as the recipient of…
Access to treatment updates
February 26, 2026
Rezurock now reimbursed in Ontario and BC! Rezurock (belumosudil) is a new treatment for chronic graft-versus-host disease (GVHD), a condition…
Myeloma Canada Welcomes Restart of pCPA Negotiations for Carvykti®
February 26, 2026
Myeloma Canada welcomes the news that negotiations between the pan‑Canadian Pharmaceutical Alliance…
Two new drugs funded in Quebec!
November 27, 2025
This month, two exciting new drug funding announcements for Quebec were made…
CDA recommends public reimbursement of Blenrep®: A step forward for Canadians living with myeloma
November 14, 2025
(Montreal, Quebec) November 13, 2025 – Myeloma Canada welcomes the Canadian Drug…
Recent decisions on treatment access and reimbursement: a quick recap
October 22, 2025
Over the last few weeks, several decisions have been made by government…
What happened with Carvykti® and why it matters to Canadians living with myeloma
October 22, 2025
What is Carvykti®? Carvykti® (ciltacabtagene autoleucel, or cilta-cel) is a type of…
National reimbursement negotiations for Carvykti® terminated without agreement, devastating Canadians with myeloma
September 30, 2025
“Carvykti® literally has the potential to save my life, yet this chance is…
5 Tips to Boost Your Myeloma Canada Ride Fundraising
May 21, 2026
Fundraising doesn’t have to feel overwhelming. Whether you’re a first-time rider or a seasoned cyclist, these…
New Faces, Fresh Ideas: Welcoming Our Newest Board Members and Staff
May 21, 2026
Myeloma Canada is growing, and we couldn’t be more excited about the people joining…
The Continuous Work of Advocacy
May 20, 2026
From the day Myeloma Canada was founded in 2005, our co-founder Aldo Del…
Announcing the 2026 Marion State Memorial Nursing Award Recipient: Nina Mason
May 8, 2026
Myeloma Canada is proud to announce Nina Mason as the recipient of…
Announcing the Myeloma Canada Community Award Recipients
April 16, 2026
The Myeloma Canada community awards honour the outstanding achievements of individuals within…
Myeloma Canada’s 2025 Aldo Del Col Research Grant: Four Projects Advancing Myeloma Treatment
April 16, 2026
The Aldo Del Col Research Grant is Myeloma Canada’s flagship research funding…
Myeloma Action Month: A Community That Showed Up
April 16, 2026
A Word from our CEO Every year, I look forward to March.…
Myeloma Action Month 2026: A Mid-Month Recap
March 19, 2026
Lighting Landmarks for Myeloma Action Month Across the globe, communities have come…
From Awareness to Action
March 19, 2026
A Word from our CEO For many years, March has been known…
Important Notice: Myeloma Monitor App Will Stop Functioning
February 26, 2026
We would like to inform you of an important change regarding the…
Join Us for the 5th Annual Myeloma Canada Ride!
February 26, 2026
Ready, set, go for the Myeloma Canada Ride, returning this Spring 2026!…
Pain Matters More Than We Sometimes Admit
February 26, 2026
A Message From our CEO In November, I underwent a total left…
Everything You Need to Know About Clinical Trials in One Place
May 21, 2026
May 20 is Clinical Trials Day, a global moment to recognize the…
Myeloma Canada’s 2025 Aldo Del Col Research Grant: Four Projects Advancing Myeloma Treatment
April 16, 2026
The Aldo Del Col Research Grant is Myeloma Canada’s flagship research funding…
Our Takeaways from ASH 2025: Real Progress and Growing Momentum in Myeloma Research
January 22, 2026
Myeloma Canada representatives joined thousands from the global hematology community at the…
Investing in the future of Canadian myeloma research: The impact of the Dr Andrew R Belch MEET Grant
November 27, 2025
Since its launch in 2019, the Dr Andrew R Belch Myeloma Education…
Canadians with myeloma share their top takeaways from the International Myeloma Society annual meeting
October 22, 2025
Each year, the International Myeloma Society (IMS) annual meeting brings together leading…
National reimbursement negotiations for Carvykti® terminated without agreement, devastating Canadians with myeloma
September 30, 2025
“Carvykti® literally has the potential to save my life, yet this chance is…
Global myeloma research: Myeloma Canada’s takeaways from international meetings
August 21, 2025
This summer, Myeloma Canada staff travelled to several international conferences to participate…
Everything You Need to Know About Clinical Trials in One Place
May 21, 2026
May 20 is Clinical Trials Day, a global moment to recognize the…
The Continuous Work of Advocacy
May 20, 2026
From the day Myeloma Canada was founded in 2005, our co-founder Aldo Del…
Access to treatment updates
February 26, 2026
Rezurock now reimbursed in Ontario and BC! Rezurock (belumosudil) is a new treatment for chronic graft-versus-host disease (GVHD), a condition…
Myeloma Canada Welcomes Restart of pCPA Negotiations for Carvykti®
February 26, 2026
Myeloma Canada welcomes the news that negotiations between the pan‑Canadian Pharmaceutical Alliance…
Patient Perspectives, Access to Treatment, and Navigating Complex Systems: A Look Back on a Year of Advocacy
January 22, 2026
In 2025, Myeloma Canada continued to advocate for a healthcare system where…
A New Year, a United Community, and a Shared Responsibility
January 22, 2026
A Word from our CEO As we begin a new year, I…
Giving Tuesday is December 2. Help us break down barriers to life-saving treatment on this global day of generosity.
November 27, 2025
Canadians living with myeloma are facing a setback in their ability to receive life-saving treatment. This Giving…
Help us fight for access to the treatments Canadians need
November 27, 2025
A word from our CEO We speak about research often and the hope it gives our…
Recent decisions on treatment access and reimbursement: a quick recap
October 22, 2025
Over the last few weeks, several decisions have been made by government…
What happened with Carvykti® and why it matters to Canadians living with myeloma
October 22, 2025
What is Carvykti®? Carvykti® (ciltacabtagene autoleucel, or cilta-cel) is a type of…
National reimbursement negotiations for Carvykti® terminated without agreement, devastating Canadians with myeloma
September 30, 2025
“Carvykti® literally has the potential to save my life, yet this chance is…
Global myeloma research: Myeloma Canada’s takeaways from international meetings
August 21, 2025
This summer, Myeloma Canada staff travelled to several international conferences to participate…
5 Tips to Boost Your Myeloma Canada Ride Fundraising
May 21, 2026
Fundraising doesn’t have to feel overwhelming. Whether you’re a first-time rider or a seasoned cyclist, these…
The Continuous Work of Advocacy
May 20, 2026
From the day Myeloma Canada was founded in 2005, our co-founder Aldo Del…
Announcing the 2026 Marion State Memorial Nursing Award Recipient: Nina Mason
May 8, 2026
Myeloma Canada is proud to announce Nina Mason as the recipient of…
Announcing the Myeloma Canada Community Award Recipients
April 16, 2026
The Myeloma Canada community awards honour the outstanding achievements of individuals within…
Myeloma Action Month 2026: A Mid-Month Recap
March 19, 2026
Lighting Landmarks for Myeloma Action Month Across the globe, communities have come…
Helpful resources to share on World Amyloidosis Day
October 22, 2025
October 26 marks World AmyloidosisA condition in which myeloma light chains (Bence…
Canadians with myeloma share their top takeaways from the International Myeloma Society annual meeting
October 22, 2025
Each year, the International Myeloma Society (IMS) annual meeting brings together leading…
The history of the Multiple Myeloma March and the people who make it happen
September 18, 2025
This year marks the 17th annual Multiple Myeloma March — a grassroots…
Work with your employer to maximize your Multiple Myeloma March fundraising
September 11, 2025
Hey Multiple Myeloma Marchers! Looking to maximize your fundraising efforts? Why not…
How to promote your local Multiple Myeloma March with social media
August 21, 2025
An interview with John Stultz Jr of the Hamilton-Niagara March The 2025…